March 27, 2019
Axcella to Present Late-Breaker Data on Lead AXA™ Candidate, AXA1665 at EASL, the International Liver Congress™
CAMBRIDGE, Mass.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/AXAcandidates?src=hash” target=”_blank”gt;#AXAcandidateslt;/agt;–Axcella Health, a biotechnology company pioneering the research and development of novel multifactorial interventions to address…